|Articles|December 1, 1998

New Developments in the Treatment of Hypertension: What the HOT Study Means to JNC-VI
Volume 4
Issue 13 Suppl

Hypertension in the Older Patient

Author(s)Gary Gerstenblith, MD

Download PDF: Hypertension in the Older Patient

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Introduction

over 27 years ago

Article

The Hypertension Optimal Treatment (HOT) Study: Implications for Hypertension Management and the J-Shape Curve

over 27 years ago

Article

Barriers to Guideline Adherence

over 27 years ago

Article

Hypertension in Managed Care

over 27 years ago

Article

Beta Blockers as First-Line Therapy for Hypertension in the Elderly

over 27 years ago

Article

Cost Effectiveness of Intensive Treatment of Hypertension

over 27 years ago

Article

Selected Abstracts

over 27 years ago

Article

CME Quiz

over 27 years ago

Article

Bibliography

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Hypertension in the Older Patient

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

5 Notable FDA Approvals From the First Half of 2026

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hypertension in the Older Patient

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer

Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL

FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma

5 Notable FDA Approvals From the First Half of 2026